Document Detail


Comparison of tissue plasminogen activator and streptokinase in the management of acute myocardial infarction.
MedLine Citation:
PMID:  2495909     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombolysis is well established as effective therapy in AMI. Two thrombolytic agents, streptokinase and tissue plasminogen activator (tPA), are now widely available for clinical use. These agents have different effects, and there has been considerable debate as to which is superior. Both are effective in preserving myocardial function and reducing mortality. However, the confidence limits of these findings overlap, and no firm conclusions can be made from comparing trials enrolling different populations with different baseline characteristics and ancillary treatments such as angioplasty. There have been few "head-to-head" comparisons. These trials show that tPA achieves better lysis rates than streptokinase, but the theoretic advantage of fibrin specificity does not result in fewer adverse effects or greater preservation of LV function. Although each drug may have specific indications, the drugs appear similar in clinical benefit, and further comparison trials are required.
Authors:
H D White
Related Documents :
3060319 - Lymphocytic angiitis following streptokinase therapy.
2223309 - Rash after treatment with anistreplase.
3935239 - Electrolyte disturbances and cardiac failure with hypomagnesaemia in anorexia nervosa.
389259 - Randomised multicentre trial of early mobilisation after uncomplicated myocardial infar...
2191849 - Intravenous streptokinase. a reappraisal of its therapeutic use in acute myocardial inf...
3711489 - Elevated serum d dimer: a degradation product of cross-linked fibrin (xdp) after intrav...
14740179 - Relation of coronary vasoreactivity and coronary calcification in asymptomatic subjects...
6450599 - Pathological view of sudden cardiac death.
17506599 - Pharmacoeconomic analysis of clopidogrel in secondary prevention of coronary artery dis...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Review    
Journal Detail:
Title:  Chest     Volume:  95     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1989 May 
Date Detail:
Created Date:  1989-06-02     Completed Date:  1989-06-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  265S-269S     Citation Subset:  AIM; IM    
Affiliation:
Cardiology Department, Green Lane Hospital, Auckland, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Double-Blind Method
Humans
Myocardial Infarction / drug therapy*
Myocardial Reperfusion / methods
Random Allocation
Streptokinase / therapeutic use*
Tissue Plasminogen Activator / therapeutic use*
Chemical
Reg. No./Substance:
EC 3.4.-/Streptokinase; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of ultrasonically nebulized distilled water and cold-air hyperventilation challenges in a...
Next Document:  Thrombolysis with tissue plasminogen activator in suspected acute myocardial infarction. The ASSET S...